UBS AM’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-211,555	Closed	-$2.55M	–	2628
2015 Q4	$2.55M	Sell	211,555 -16,645	-7%	-$201K	﹤0.01%	1331
2015 Q3	$2.73M	Sell	228,200 -31,900	-12%	-$382K	﹤0.01%	1280
2015 Q2	$4.77M	Buy	+260,100	New	+$4.77M	﹤0.01%	1069